PUBLIC DISCLOSURE & CLARIFICATION

BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.

CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.

5'-O-(4,4'-Dimethoxytrityl)-2'-beta-C-methyl adenosine

Inquiry

Cat. No.: X25-06-LY891

5'-O-(4,4'-Dimethoxytrityl)-2'-beta-C-methyl adenosine

Synonym: 2305415-95-4; (2R,3R,4R,5R)-2-(6-Aminopurin-9-yl)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-methyloxolane-3,4-diol; 5a-O-(4,4a-Dimethoxytrityl)-2a-beta-C-methyl adenosine

CAS Number: 2305415-95-4
Compound CID: 168449281

Product Size

50 mg; 100 mg; 250 mg; 500 mg

Price

Datasheet

MSDS

Properties

Description

5'-O-(4,4'-Dimethoxytrityl)-2'-beta-C-methyl adenosine is a modified adenosine with a 5 '-O-(4,4'-dimethoxy-triphenylmethyl) protecting group and 2 '-β-C-methyl modification.

Molecular Weight

583.63

Molecular Formula

C₃₂H₃₃N₅O₆

Form

Solid

Purity

≥95.0%

Applications

5'-O-(4,4'-Dimethoxytrityl)-2'-beta-C-methyl adenosine can be used to study the mechanisms of RNA processing and translation, especially when researching the interaction between RNA and proteins. Meanwhile, it can also be used to synthesize nucleotide derivatives with biological activity and study their roles in cell signal transduction.

Publications

Publications (0)

Publications

Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.